Home » Topics » Science » Biomarkers

Biomarkers
RSS

Inwardly rectifying potassium channel, a novel immune target in MS

Oct. 15, 2012

Forkhead box M1 expression predictive of survival in patients with renal cell carcinoma

Oct. 15, 2012

Plasma thymosin alpha-1 levels may distinguish renal cell carcinoma from urothelial carcinoma

Oct. 15, 2012

Researchers find possible biomarker for renal cell carcinoma

Oct. 11, 2012

Potential predictor of sunitinib response in renal cell carcinoma identified

Oct. 10, 2012

FDA approves the Dexcom G4 PLATINUM continuous glucose monitoring system

Oct. 9, 2012

Beta-amyloid 17 identified as a potential blood biomarker of early Alzheimer's disease

Sep. 27, 2012

Melatonin identified as a marker of brain serotonin metabolism

Sep. 26, 2012

Sequestosome-1 identified as a biomarker of melanoma

Sep. 25, 2012

Plasma serotonin as indicator of stable heart disease outcomes

Sep. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...